White label ELPA - ClinicalTrials.eu

A Study of S-337395 for Adults Not in Hospital with Respiratory Syncytial Virus Who Are at High Risk of Severe Disease

Recruiting

2 1
Investigated Diseases:
- Respiratory syncytial virus infection
A Study Testing Drug Combination for Heart Failure in Women Comparing Increased Doses to Standard Care

Recruiting

3 1 1 1
Investigated Diseases:
- Cardiac failure
Investigated Drugs:
A study to evaluate the long-term safety and effectiveness of afimkibart in patients with atopic dermatitis who took part in previous afimkibart studies

Recruiting

2 1
Investigated Drugs:
- Ro7790121
Testing WIN378 Safety and Effects in Adults with Moderate or Severe Asthma

Recruiting

2 1
Investigated Diseases:
- Asthma
Investigated Drugs:
- HUMAN IGG1 MONOCLONAL ANTIBODY AGAINST TSLP
Study of divarasib and pembrolizumab compared to standard chemotherapy in previously untreated KRAS G12C-mutated advanced non-small cell lung cancer

Recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
+6
A study to evaluate the effectiveness and safety of pridopidine hydrochloride in patients with amyotrophic lateral sclerosis

Recruiting

3 1 1
Investigated Diseases:
- Amyotrophic lateral sclerosis
+3
Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity

Recruiting

3 1
Investigated Diseases:
- Cardiac failure
- Obesity
+4
A study to evaluate the effects of obicetrapib and ezetimibe on cholesterol levels in adults with type 2 diabetes or metabolic syndrome

Recruiting

3 1
Investigated Diseases:
- Type 2 diabetes mellitus
Investigated Drugs:
- Obicetrapib
- Ezetimibe
A study to evaluate the effectiveness of NAV-240 in adults with moderate-to-severe hidradenitis suppurativa

Recruiting

2 1 1
Investigated Drugs:
- IMB 101
- Sodium Chloride
A study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.

Recruiting

3 1 1
Investigated Drugs:
- Lebrikizumab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies